These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 3337907)

  • 1. Plasma cell karyotype in multiple myeloma.
    Gould J; Alexanian R; Goodacre A; Pathak S; Hecht B; Barlogie B
    Blood; 1988 Feb; 71(2):453-6. PubMed ID: 3337907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple chromosomal abnormalities in fulminant anaplastic myeloma.
    Maslovsky I; Lugassy G; Blumental R; Ducach A; Yehuda O; Abeliovich D
    Clin Lab Haematol; 1999 Jun; 21(3):207-10. PubMed ID: 10448603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of cytogenetics in multiple myeloma.
    Seong C; Delasalle K; Hayes K; Weber D; Dimopoulos M; Swantkowski J; Huh Y; Glassman A; Champlin R; Alexanian R
    Br J Haematol; 1998 Apr; 101(1):189-94. PubMed ID: 9576200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Der(16)t(1;16)(q10;p10) in multiple myeloma: a new non-random abnormality that is frequently associated with Burkitt's-type translocations.
    Mugneret F; Sidaner I; Favre B; Manone L; Maynadié M; Caillot D; Solary E
    Leukemia; 1995 Feb; 9(2):277-81. PubMed ID: 7869764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between cytogenetic abnormalities and disease characteristics in multiple myeloma: monosomy of chromosome 13 and structural abnormalities of 11q are associated with a high percentage of S-phase plasma cells.
    Gutiérrez NC; Hernández JM; García JL; Almeida J; Mateo G; González MI; Hernández J; Fernández-Calvo J; San Miguel JF
    Haematologica; 2000 Nov; 85(11):1146-52. PubMed ID: 11064466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Karyotypic evolution in multiple myeloma.
    MacKenzie MR; Lewis JP
    Cancer Genet Cytogenet; 1985 Aug; 17(4):301-5. PubMed ID: 4016715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PAX5-positive plasma cell myeloma with t(9;14;11)(p13;q32;q13), a novel complex variant translocation of t(11;14)(q13;q32) and t(9;14)(p13;q32).
    Sato K; Sakai H; Kato M; Nishio Y; Tsuruoka Y; Uemura Y; Yokoi S; Saito T; Matsunawa M; Suzuki Y; Isobe Y; Inoue Y; Takahashi M; Miura I
    Int J Hematol; 2015 Jun; 101(6):608-11. PubMed ID: 25633778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Karyotype in multiple myeloma and plasma cell leukaemia.
    Weh HJ; Gutensohn K; Selbach J; Kruse R; Wacker-Backhaus G; Seeger D; Fiedler W; Fett W; Hossfeld DK
    Eur J Cancer; 1993; 29A(9):1269-73. PubMed ID: 8343266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytogenetic findings in 200 patients with multiple myeloma.
    Sawyer JR; Waldron JA; Jagannath S; Barlogie B
    Cancer Genet Cytogenet; 1995 Jul; 82(1):41-9. PubMed ID: 7627933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonrandom chromosomal rearrangements of 14q32.3 and 19p13.3 and preferential deletion of 1p in 21 patients with multiple myeloma and plasma cell leukemia.
    Taniwaki M; Nishida K; Takashima T; Nakagawa H; Fujii H; Tamaki T; Shimazaki C; Horiike S; Misawa S; Abe T
    Blood; 1994 Oct; 84(7):2283-90. PubMed ID: 7919347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicolor spectral karyotyping identifies new recurring breakpoints and translocations in multiple myeloma.
    Rao PH; Cigudosa JC; Ning Y; Calasanz MJ; Iida S; Tagawa S; Michaeli J; Klein B; Dalla-Favera R; Jhanwar SC; Ried T; Chaganti RS
    Blood; 1998 Sep; 92(5):1743-8. PubMed ID: 9716604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissecting karyotypic patterns in non-hyperdiploid multiple myeloma: an overview on the karyotypic evolution.
    Jimenez-Zepeda VH; Braggio E; Fonseca R
    Clin Lymphoma Myeloma Leuk; 2013 Oct; 13(5):552-8. PubMed ID: 23856591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple myeloma and acute myelomonocytic leukemia: simultaneous occurrence without previous chemotherapy.
    Annino L; Martino P; Barsotti P; Serra P; Marinozzi V; Mandelli F
    Acta Haematol; 1980; 64(4):195-200. PubMed ID: 6781197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Ig heavy chain gene is frequently involved in chromosomal translocations in multiple myeloma and plasma cell leukemia as detected by in situ hybridization.
    Nishida K; Tamura A; Nakazawa N; Ueda Y; Abe T; Matsuda F; Kashima K; Taniwaki M
    Blood; 1997 Jul; 90(2):526-34. PubMed ID: 9226151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromosome aberrations in a series of 120 multiple myeloma cases with abnormal karyotypes.
    Mohamed AN; Bentley G; Bonnett ML; Zonder J; Al-Katib A
    Am J Hematol; 2007 Dec; 82(12):1080-7. PubMed ID: 17654686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytogenetic study of 30 patients with multiple myeloma: comparison of 3 and 6 day bone marrow cultures stimulated or not with cytokines by using a miniaturized karyotypic method.
    Brigaudeau C; Trimoreau F; Gachard N; Rouzier E; Jaccard A; Bordessoule D; Praloran V
    Br J Haematol; 1997 Mar; 96(3):594-600. PubMed ID: 9054668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosome abnormalities clustering and its implications for pathogenesis and prognosis in myeloma.
    Debes-Marun CS; Dewald GW; Bryant S; Picken E; Santana-Dávila R; González-Paz N; Winkler JM; Kyle RA; Gertz MA; Witzig TE; Dispenzieri A; Lacy MQ; Rajkumar SV; Lust JA; Greipp PR; Fonseca R
    Leukemia; 2003 Feb; 17(2):427-36. PubMed ID: 12592343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple myeloma with discordant M components in the serum and CSF.
    Dotten DA; Pruzanski W
    Arch Intern Med; 1981 Sep; 141(10):1374-6. PubMed ID: 6791605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-random chromosomal aberrations associated with multiple myeloma.
    Lewis JP; MacKenzie MR
    Hematol Oncol; 1984; 2(4):307-17. PubMed ID: 6335483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytogenetic abnormalities correlate with the plasma cell labeling index and extent of bone marrow involvement in myeloma.
    Rajkumar SV; Fonseca R; Dewald GW; Therneau TM; Lacy MQ; Kyle RA; Greipp PR; Gertz MA
    Cancer Genet Cytogenet; 1999 Aug; 113(1):73-7. PubMed ID: 10459351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.